Ian Henshaw

Ian Henshaw is an accomplished executive with extensive experience in the biopharmaceutical sector, currently serving as Senior Vice President and Global Head of Biosimilars at Biogen since May 2015. Henshaw has held various leadership roles, including Vice President of Biogen's Biosimilar Business Unit and Chief of Staff for Business Operations and Alliance Management. Previous positions include Non-Executive Director at Samsung Bioepis and Vice President roles at The Medicines Company, where responsibilities encompassed strategy, business development, and global leadership in neurocritical care and emerging markets. Henshaw began a professional career as an Engineer at Davy Process Technology and has a strong educational background with an MBA from Cranfield School of Management and a BEng in Chemical and Process Engineering from Newcastle University.